vs

Side-by-side financial comparison of PHOTRONICS INC (PLAB) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $210.4M, roughly 1.0× PHOTRONICS INC). PHOTRONICS INC runs the higher net margin — 10.9% vs 5.8%, a 5.1% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs -5.5%). PHOTRONICS INC produced more free cash flow last quarter ($25.2M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs -3.8%).

Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

PLAB vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.0× larger
UTI
$220.8M
$210.4M
PLAB
Growing faster (revenue YoY)
UTI
UTI
+15.1% gap
UTI
9.6%
-5.5%
PLAB
Higher net margin
PLAB
PLAB
5.1% more per $
PLAB
10.9%
5.8%
UTI
More free cash flow
PLAB
PLAB
$44.4M more FCF
PLAB
$25.2M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
-3.8%
PLAB

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
PLAB
PLAB
UTI
UTI
Revenue
$210.4M
$220.8M
Net Profit
$22.9M
$12.8M
Gross Margin
33.7%
Operating Margin
22.9%
7.1%
Net Margin
10.9%
5.8%
Revenue YoY
-5.5%
9.6%
Net Profit YoY
-32.4%
-42.1%
EPS (diluted)
$0.39
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLAB
PLAB
UTI
UTI
Q4 25
$220.8M
Q3 25
$210.4M
$222.4M
Q2 25
$211.0M
$204.3M
Q1 25
$212.1M
$207.4M
Q4 24
$222.6M
$201.4M
Q3 24
$211.0M
$196.4M
Q2 24
$217.0M
$177.5M
Q1 24
$216.3M
$184.2M
Net Profit
PLAB
PLAB
UTI
UTI
Q4 25
$12.8M
Q3 25
$22.9M
$18.8M
Q2 25
$8.9M
$10.7M
Q1 25
$42.9M
$11.4M
Q4 24
$33.9M
$22.2M
Q3 24
$34.4M
$18.8M
Q2 24
$36.3M
$5.0M
Q1 24
$26.2M
$7.8M
Gross Margin
PLAB
PLAB
UTI
UTI
Q4 25
Q3 25
33.7%
Q2 25
36.9%
Q1 25
35.6%
Q4 24
37.0%
Q3 24
35.6%
Q2 24
36.5%
Q1 24
36.6%
Operating Margin
PLAB
PLAB
UTI
UTI
Q4 25
7.1%
Q3 25
22.9%
11.2%
Q2 25
26.4%
6.9%
Q1 25
24.6%
8.1%
Q4 24
25.1%
13.6%
Q3 24
24.7%
13.3%
Q2 24
25.8%
4.2%
Q1 24
26.6%
6.1%
Net Margin
PLAB
PLAB
UTI
UTI
Q4 25
5.8%
Q3 25
10.9%
8.4%
Q2 25
4.2%
5.2%
Q1 25
20.2%
5.5%
Q4 24
15.2%
11.0%
Q3 24
16.3%
9.6%
Q2 24
16.7%
2.8%
Q1 24
12.1%
4.2%
EPS (diluted)
PLAB
PLAB
UTI
UTI
Q4 25
$0.23
Q3 25
$0.39
$0.33
Q2 25
$0.15
$0.19
Q1 25
$0.68
$0.21
Q4 24
$0.54
$0.40
Q3 24
$0.55
$0.35
Q2 24
$0.58
$0.09
Q1 24
$0.42
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLAB
PLAB
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$575.8M
$162.8M
Total DebtLower is stronger
$16.0K
$101.4M
Stockholders' EquityBook value
$1.1B
$335.9M
Total Assets
$1.8B
$834.0M
Debt / EquityLower = less leverage
0.00×
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLAB
PLAB
UTI
UTI
Q4 25
$162.8M
Q3 25
$575.8M
$169.1M
Q2 25
$558.4M
$70.7M
Q1 25
$642.2M
$96.0M
Q4 24
$640.7M
$172.0M
Q3 24
$606.4M
$161.9M
Q2 24
$559.9M
$115.5M
Q1 24
$521.5M
$116.1M
Total Debt
PLAB
PLAB
UTI
UTI
Q4 25
$101.4M
Q3 25
$16.0K
$87.1M
Q2 25
$19.0K
$73.8M
Q1 25
$21.0K
$94.4M
Q4 24
$25.0K
$120.1M
Q3 24
$28.0K
$125.7M
Q2 24
$2.5M
$137.3M
Q1 24
$2.7M
$141.9M
Stockholders' Equity
PLAB
PLAB
UTI
UTI
Q4 25
$335.9M
Q3 25
$1.1B
$328.1M
Q2 25
$1.1B
$306.8M
Q1 25
$1.1B
$293.9M
Q4 24
$1.1B
$280.0M
Q3 24
$1.1B
$260.2M
Q2 24
$1.0B
$239.4M
Q1 24
$1.0B
$232.6M
Total Assets
PLAB
PLAB
UTI
UTI
Q4 25
$834.0M
Q3 25
$1.8B
$826.1M
Q2 25
$1.7B
$740.8M
Q1 25
$1.7B
$720.4M
Q4 24
$1.7B
$753.8M
Q3 24
$1.6B
$744.6M
Q2 24
$1.6B
$706.0M
Q1 24
$1.6B
$702.1M
Debt / Equity
PLAB
PLAB
UTI
UTI
Q4 25
0.30×
Q3 25
0.00×
0.27×
Q2 25
0.00×
0.24×
Q1 25
0.00×
0.32×
Q4 24
0.00×
0.43×
Q3 24
0.00×
0.48×
Q2 24
0.00×
0.57×
Q1 24
0.00×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLAB
PLAB
UTI
UTI
Operating Cash FlowLast quarter
$50.1M
$3.1M
Free Cash FlowOCF − Capex
$25.2M
$-19.2M
FCF MarginFCF / Revenue
12.0%
-8.7%
Capex IntensityCapex / Revenue
11.8%
10.1%
Cash ConversionOCF / Net Profit
2.19×
0.24×
TTM Free Cash FlowTrailing 4 quarters
$64.5M
$16.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLAB
PLAB
UTI
UTI
Q4 25
$3.1M
Q3 25
$50.1M
$57.1M
Q2 25
$31.5M
$18.1M
Q1 25
$78.5M
$-789.0K
Q4 24
$68.4M
$23.0M
Q3 24
$75.1M
$67.5M
Q2 24
$76.5M
$10.0M
Q1 24
$41.5M
$-2.5M
Free Cash Flow
PLAB
PLAB
UTI
UTI
Q4 25
$-19.2M
Q3 25
$25.2M
$40.6M
Q2 25
$-29.1M
$6.8M
Q1 25
$43.3M
$-11.7M
Q4 24
$25.2M
$19.6M
Q3 24
$50.7M
$60.0M
Q2 24
$56.5M
$3.0M
Q1 24
$-1.8M
$-8.4M
FCF Margin
PLAB
PLAB
UTI
UTI
Q4 25
-8.7%
Q3 25
12.0%
18.3%
Q2 25
-13.8%
3.4%
Q1 25
20.4%
-5.7%
Q4 24
11.3%
9.7%
Q3 24
24.0%
30.6%
Q2 24
26.0%
1.7%
Q1 24
-0.8%
-4.6%
Capex Intensity
PLAB
PLAB
UTI
UTI
Q4 25
10.1%
Q3 25
11.8%
7.4%
Q2 25
28.7%
5.5%
Q1 25
16.6%
5.3%
Q4 24
19.4%
1.7%
Q3 24
11.6%
3.8%
Q2 24
9.2%
4.0%
Q1 24
20.0%
3.2%
Cash Conversion
PLAB
PLAB
UTI
UTI
Q4 25
0.24×
Q3 25
2.19×
3.04×
Q2 25
3.55×
1.69×
Q1 25
1.83×
-0.07×
Q4 24
2.02×
1.04×
Q3 24
2.18×
3.58×
Q2 24
2.11×
2.01×
Q1 24
1.59×
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLAB
PLAB

High End Integrated Circuits$53.6M25%
High End Flat Panel Displays$53.5M25%
KR$43.7M21%
Other$42.1M20%
Mainstream Flat Panel Displays$9.1M4%
Transferred At Point In Time$8.4M4%

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

Related Comparisons